CD28/CTLA4 gene region on chromosome 2q33 confers genetic susceptibility to celiac disease. A linkage and family-based association study

Tissue Antigens

Volumn 53, Issue 5, 1999, Pages 470-475

  Holopainen, P ^a   Arvas, M ^a   Sistonen, P ^a   Mustalahti, K ^b   Collin, P ^b   Maki M ^b   Partanen, J ^a  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Chromosome2; CTLA4; Gluten sensitive enteropathy; Linkage analysis; Transmission disequilibrium test

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLIADIN; HLA DQ ANTIGEN;

ARTICLE; AUTOIMMUNE DISEASE; CELIAC DISEASE; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HISTOCOMPATIBILITY GENE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DIFFERENTIATION; CELIAC DISEASE; CHROMOSOMES, HUMAN, PAIR 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOCONJUGATES; LINKAGE (GENETICS);

EID: 0032950943     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.1999.530503.x     Document Type: Article

References (32)

1. 1. Strober W. Gluten-sensitive enteropathy. In: King RA, Rotter JI, Motulsky AG, eds. The genetic basis of common diseases. New York: Oxford University Press, 1992: 279-304.
2. 2. Mäki M, Collin P. Celiac disease Lancet 1997: 349: 1755-9.
3. 3. Sollid L, Thorsby E. HLA susceptibility genes in celiac disease: Genetic mapping and role in pathogenesis. Gastroenterology 1993: 105: 910-22.
4. 4. Polvi A, Arranz E, Fernandez-Arquero M et al. HLA-DQ2-negative celiac disease in Finland and Spain. Hum Immunol 1998: 59: 169-75.
5. 5. Petronzelli F, Bonamico M, Ferrante P et al. Genetic contribution of the HLA region to the familial clustering of coeliac disease. Ann Hum Genet 1997: 61: 307-17.
6. 6. Zhong F, McCombs CC, Olson JM et al. An autosomal screen for genes that predispose to celiac disease in the western counties of Ireland. Nat Genet 1996: 14: 329-33.
7. 7. Greco L, Corazza G, Babron MC et al. Genome search in celiac disease. Am J Hum Genet 1998: 62: 669-75.
8. 8. Houlston RS, Tomlinson IPM, Ford D et al. Linkage analysis of candidate regions for coeliac disease genes. Hum Mol Genet 1997: 6: 1335-9.
9. 9. MacDonald TT. The role of activated T lymphocytes in gastrointestinal disease. Clin Exp Allergy 1990: 20: 247-52.
10. 10. O'Farrelly C, Gallagher RB. Intestinal gluten sensitivity: snapshots of an unusual autoimmune-like disease. Immunol Today 1992: 13: 474-6.
11. 11. Mäki M. Coeliac disease and autoimmunity due to unmasking of cryptic epitopes? Lancet 1996: 348: 1046-7.
12. 12. Sperling AI, Bluestone JA. The complexities of T-cell costimulation: CD28 and beyond. Immunol Rev 1996: 153: 155 82.
13. 13. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997: 7: 445-50.
14. 14. Karandikar NJ, Vanderlugt CL, Walunas TL, Miller SD, Bluestone JA. CTLA-4: A negative regulator of autoimmune disease. J Exp Med 1996: 184: 783-8.
15. 15. Harper K, Balzano C, Rouvier E, Mattéi MG, Luciani MF, Golstein P. CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 1991: 147: 1037-44.
16. 16. Nisticó L, Buzzetti R, Pritchard LE et al. The CTLA4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996: 5: 1075-80.
17. 17. Donner H, Rau H, Walfish PG et al. CTLA4 Alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinal Metab 1997: 82: 143-6.
18. 18. Marron MP, Raffel L, Garchon HL et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet 1997: 6: 1275-82.
19. 19. Yanagawa T, Hikada Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995: 80: 41-5.
20. 20. Kotsa K, Watson PF, Weetman AP. A CTLA-4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol 1997: 46: 551-4.
21. 21. Seidl C, Donner H, Fischer B et al. CTLA4 codon 17 dimorphism in patients with rheumatoid arthritis. Tissue Antigens 1998: 51: 62-6.
22. 22. Djilali-Saiah I, Schmitz J, Harfouch-Hammoud E, Mougenot JF, Bach JF, Caillat-Zucman S. CTLA4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998: 43: 187-9.
23. 23. Kruglyak L, Daly MJ, Reeve-Daly MP, Lander ES. Parametric and non-parametric linkage analysis: A unified multipoint approach. Am J Hum Genet 1996: 58: 1347-63.
24. 24. Kong A, Cox NJ. Allele-sharing models: LOD scores and accurate linkage tests. Am J Hum Genet 1997: 61: 1179-88.
25. 25. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 1995: 11: 241-7.
26. 26. Ewens WJ, Spielman RS. Disease associations and the transmission/disequilibrium test (TDT). In: Dracopoli NC, Haines JL, Korf BR et al., eds. Current Protocols in Human Genetics. Vol 1. New York: John Wiley & Sons, Inc., 1997: 1.12.1 1.12.13.
27. 27. Duffy DL. Sib-pair: a program for nonparametric linkage/association analysis. Am J Hum Genet 1997: 61 (Suppl): A197.
28. 28. Molberg O, Mcadam SN, Körner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T-cells in celiac disease. Nature Med 1998: 4: 713-7.
29. 29. Lundin KEA, Scott H, Hansen T et al. Gliadin-specific, HLA DQ(A1*0501, B1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993: 178: 187-96.
30. 30. Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997: 3: 797-801.
31. 31. Kuchroo VK, Das MP, Brown JA et al. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune therapy. Cell 1995: 80: 707-18.
32. 32. Lenschow DJ, Ho SC, Sattar H et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the non obese diabetic mouse. J Exp Med 1995: 181: 1145-55.